Zhenhui Lu

1.3k total citations
51 papers, 950 citations indexed

About

Zhenhui Lu is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Zhenhui Lu has authored 51 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 15 papers in Infectious Diseases and 13 papers in Surgery. Recurrent topics in Zhenhui Lu's work include Tuberculosis Research and Epidemiology (12 papers), Asthma and respiratory diseases (6 papers) and Diagnosis and treatment of tuberculosis (5 papers). Zhenhui Lu is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Asthma and respiratory diseases (6 papers) and Diagnosis and treatment of tuberculosis (5 papers). Zhenhui Lu collaborates with scholars based in China, Japan and Canada. Zhenhui Lu's co-authors include Weiqi Yan, Guomin Xiao, Wei Jing, Weimin Wang, Liping Yan, Wenwen Sun, Lin Fan, Yuejuan Zheng, Xin Jiang and Shaoyan Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zhenhui Lu

44 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenhui Lu China	15	355	251	223	138	127	51	950
Ruihua Yin China	20	435 1.2×	316 1.3×	138 0.6×	246 1.8×	168 1.3×	38	1.5k
John J. Moran United States	19	181 0.5×	275 1.1×	87 0.4×	75 0.5×	226 1.8×	53	1.2k
Livia A. Veress United States	18	257 0.7×	140 0.6×	208 0.9×	350 2.5×	96 0.8×	45	1.2k
Alexander Lowenthal Israel	14	157 0.4×	145 0.6×	84 0.4×	118 0.9×	159 1.3×	36	672
Vered Shani Israel	12	535 1.5×	426 1.7×	333 1.5×	48 0.3×	39 0.3×	14	1.2k
Nadeem Fazal United States	17	361 1.0×	221 0.9×	40 0.2×	114 0.8×	91 0.7×	79	1.2k
Francesco Perna Italy	17	307 0.9×	177 0.7×	37 0.2×	122 0.9×	74 0.6×	37	1.1k
Jin Shang China	17	220 0.6×	347 1.4×	345 1.5×	613 4.4×	137 1.1×	37	1.5k
Jie Ren China	18	128 0.4×	474 1.9×	154 0.7×	354 2.6×	205 1.6×	55	1.4k
Marco Bertini Italy	17	368 1.0×	143 0.6×	66 0.3×	42 0.3×	189 1.5×	38	1.1k

Countries citing papers authored by Zhenhui Lu

Since Specialization

Citations

This map shows the geographic impact of Zhenhui Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhui Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhui Lu more than expected).

Fields of papers citing papers by Zhenhui Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenhui Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhui Lu. The network helps show where Zhenhui Lu may publish in the future.

Co-authorship network of co-authors of Zhenhui Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenhui Lu. A scholar is included among the top collaborators of Zhenhui Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenhui Lu. Zhenhui Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qin, Yu, Jian Yang, Xiaojie Li, et al.. (2025). Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning. BMC Infectious Diseases. 25(1). 1225–1225. 1 indexed citations

Li, Bing, Yu Qian, Yu Wang, et al.. (2025). Global, regional, and national temporal trend in burden of chronic respiratory diseases from 1990 to 2021: Findings from the Global Burden of Disease Study 2021. Chinese Medical Journal. 138(24). 3443–3456.

Zhang, Shaoyan, Jiajun Chen, Lei Qiu, et al.. (2025). Bufei Jiedu Formula enhances CD40 activation and macrophage polarization to eliminate intracellular MRSA persisters. Frontiers in Immunology. 16. 1623182–1623182.

Zhang, Shaoyan, Xing Huang, Lei Qiu, et al.. (2025). Delayed administration of Jiuwei Qianghuo Decoction combined with Zhuye Shigao Decoction mitigates the severity of influenza A virus infection by inhibiting cell death and alleviating the subsequent cytokine storm response. Journal of Ethnopharmacology. 355(Pt A). 120572–120572.

Zhang, Shun-Xian, Jian Yang, Wenting Zhou, et al.. (2024). Global, regional, and national burden of HIV-negative tuberculosis, 1990–2021: findings from the Global Burden of Disease Study 2021. Infectious Diseases of Poverty. 13(1). 60–60. 18 indexed citations

Fan, Yaxin, Yu‐Jih Su, Zhengyi Zhang, et al.. (2024). Risk factors for readmission within one year after acute exacerbations of bronchiectasis in a Chinese tertiary hospital: a retrospective cohort study. BMC Pulmonary Medicine. 24(1). 616–616.

Zhang, Shaoyan, Lei Qiu, Shun-Xian Zhang, et al.. (2024). Efficacy and Safety of Bufei Jiedu Granules in Treating Multidrug-Resistant Pulmonary Tuberculosis: A Multi-center, Double-Blinded and Randomized Controlled Trial. Chinese Journal of Integrative Medicine. 30(7). 579–587. 1 indexed citations

Wang, Yu, Yuwei Jiang, Shaoyan Zhang, et al.. (2024). Jiawei Yanghe Decoction attenuate allergic airway inflammation by suppressing group 2 innate lymphoid cells responses. Journal of Ethnopharmacology. 326. 117927–117927. 5 indexed citations

Zhang, Shun-Xian, Yuwei Jiang, Tian Li, et al.. (2023). Elucidation of the underlying mechanism of Hua-ban decoction in alleviating acute lung injury by an integrative approach of network pharmacology and experimental verification. Molecular Immunology. 156. 85–97.

10.

Zhang, Hongchun, et al.. (2022). The Efficacy and Safety of Xinjia Xuanbai Chengqi Granules in Acute Exacerbation of COPD: A Multicentre, Randomised, Double-Blind, Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2022. 1–8.

11.

Li, Cui, Guangbo Ge, Shaoyan Zhang, et al.. (2021). Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma. Frontiers in Pharmacology. 12. 703724–703724. 12 indexed citations

12.

An, Ying, et al.. (2021). Risk prediction using the National Early Warning Score and the Worthing Physiological Scoring System in patients who were transported to the Intensive Care Unit from the Emergency Department: A cohort study. Intensive and Critical Care Nursing. 64. 103015–103015. 6 indexed citations

13.

Sun, Jinxia, et al.. (2021). Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress. Journal of Ethnopharmacology. 282. 114595–114595. 36 indexed citations

14.

Zhang, Shaoyan, Tong Zhang, Cui Li, et al.. (2020). Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen. Infectious Diseases of Poverty. 9(1). 50–50. 34 indexed citations

15.

Lu, Zhenhui, Jing Zhang, Henry Lynn, et al.. (2019). Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China. PLoS ONE. 14(11). e0225361–e0225361. 16 indexed citations

16.

Lynn, Henry, et al.. (2018). Efficacy of Jia Wei Yang He formula as an adjunctive therapy for asthma: study protocol for a randomized, double blinded, controlled trial. Trials. 19(1). 355–355. 2 indexed citations

17.

Li, Jia, et al.. (2018). Effects of serum N-terminal pro B-type natriuretic peptide& D-dimer levels on patients with acute ischemic stroke. Pakistan Journal of Medical Sciences. 34(4). 994–998. 8 indexed citations

18.

Liu, Xiaoyan, Zhenhui Lu, Ligang Wu, et al.. (2017). Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis. Oncology Letters. 13(5). 3457–3464. 20 indexed citations

19.

Li, Jia, et al.. (2015). Analysis of catechol-O-methyltransferase gene mutation and identification of new pathogenic gene for paroxysmal kinesigenic dyskinesia. Neurological Sciences. 37(3). 377–383. 1 indexed citations

20.

Zheng, Yuejuan, Xin Jiang, Feng Gao, et al.. (2014). Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome. BMC Complementary and Alternative Medicine. 14(1). 400–400. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact